Resilient Interim Results, Essex Bio-Technology Drives Growth and Innovation
Key Results Highlights: – Revenue Growth: 5.8% increase to approximately HK$876.5 million.– Net Profit Increase: 3.8% rise to HK$163.4 million, driven by operational efficiency. – Interim Dividend: Proposed at HK$0.07 cents […]